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Introduction
EGF is a mitogen that regulates multiple cellular processes,   
including proliferation, survival, and differentiation. EGF also 
exerts neurotrophic or neuromodulatory effects to regulate neu-
ronal activity (Rosenberg and Noble, 1989; Goldshmit et al.,   
2004; Takebayashi et al., 2004; Kasai et al., 2005). EGF binds 
to the EGF receptor to initiate signal transduction through mul-
tiple downstream signal mediators. For neurons, it has become 
increasingly clear that regulation of protein expression fre-
quently occurs at the level of posttranscription, such as RNA 
mobilization and local translation (Lin and Holt, 2007; Bassell 
and Warren, 2008; Costa-Mattioli et al., 2009). Given the docu-
mented action of EGF in neurons, it is unclear whether and how 
EGF may regulate gene and protein expression at the post-
transcriptional level.
As demonstrated in studies of opioid receptor (OR) gene 
knockout models, activation of ORs could modulate pain sensa-
tion, cognition functions, and animal behavior (Gavériaux-Ruff 
and Kieffer, 2002; Kieffer and Gavériaux-Ruff, 2002). There 
are three ORs, which are designated , , and . All three ORs 
are detected in the developing central and peripheral nerve sys-
tems (Zhu et al., 1998; Land et al., 2008). -OR (KOR) signal-
ing affects multiple physiological processes, including diuresis, 
dysphoria, stress response, and pain sensations (Kieffer and 
Gavériaux-Ruff, 2002; Ko et al., 2003; Ansonoff et al., 2006; 
Bruchas et al., 2007). Previously, we demonstrated that KOR 
translation could be enhanced by the axon guidance cue netrin-1   
through FAK and Grb7 (growth factor receptor–bound protein 7)   
signaling (Tsai et al., 2006, 2007). In this study, we identify a 
new mechanism underlying the stimulating effect of EGF on 
KOR expression and demonstrate a unique signaling pathway 
of EGF in coordinately facilitating nuclear export and transla-
tion of a specific mRNA.
W
e report the first example of a coordinated 
dual action of epidermal growth factor (EGF)   
in stimulating the nuclear–cytoplasmic export 
and translation of a select messenger RNA (mRNA).   
The effect of EGF is mediated by the RNA-binding pro-
tein  Grb7  (growth  factor  receptor–bound  protein  7),   
which  serves  as  an  adaptor  for  a  specific  mRNA– 
protein export complex and a translational regulator. 
Using the –opioid receptor (OR [KOR]) as a model, 
we demonstrate that EGF activates nuclear SHP-2 (Src 
homology region 2–containing tyrosine phosphatase), 
which  dephosphorylates  Grb7  in  the  nucleus.  Hypo-
phosphorylated  Grb7  binds  to  the  KOR  mRNA  and 
recruits the Hu antigen R–exportin-1 (CRM1) complex 
to form a nuclear–cytoplasmic export complex that ex-
ports KOR mRNA. EGF also activates focal adhesion 
kinase in the cytoplasm to rephosphorylate Grb7, re-
leasing KOR mRNA for active translation. In summary, 
this  study  uncovers  a  coordinated,  dual  activity  of 
EGF in facilitating nuclear export of a specific mRNA– 
protein complex as well as translational activation of 
the exported mRNA.
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We  found  that  HuR-specific  siRNA  reduced  Grb7  export 
(Fig.  2  A)  and  blocked  EGF-stimulated  cytoplasmic  accu-
mulation of Grb7 (Fig. 2 B), which was rescued by express-
ing siRNA off-target HuR (see Materials and methods). The 
HuR-interacting domain of Grb7 was previously mapped to the   
N-terminal  segment  (Tsai  et  al.,  2008).  Because  the  RNA- 
binding domain of Grb7 is also located in its N terminus (Tsai   
et  al.,  2007),  a  more  detailed  mapping  was  performed  to 
determine  the  minimal  HuR-interacting  motif  (Fig.  2  C).   
A dominant-negative mutant of Grb7 was made by deleting this 
HuR-interacting motif, called 9. The 9 mutant was detected 
in HuR interaction yet retained the KOR mRNA–binding ability 
(Fig. S2). The 9 and wild-type (WT) Grb7s were each fused to 
CFP and tested in FISH experiments. It appeared that WT CFP-
Grb7 could be exported together with KOR mRNA, whereas 
9 CFP-Grb7 remained trapped in the nucleus along with KOR 
mRNA in both DRG neurons and P19 cells (Fig. 2 D). The 
amount of KOR protein was not elevated by EGF treatment in 
P19 cells expressing 9 Flag-Grb7 but was effectively elevated 
by EGF in control cells and cells expressing WT Flag-Grb7 
(Fig. 2 E). These results confirmed that the HuR–Grb7 complex 
is involved in exporting KOR mRNA to the cytoplasm.
Nuclear export of Grb7 is mediated by  
HuR and CRM1
HuR utilizes three different complexes for nuclear export, in-
cluding  exportin-1  (also  known  as  CRM1)  and  transportin 
1 and 2 (Brennan et al., 2000; Rebane et al., 2004). There-
fore,  we  wanted  to  determine  the  specific  export  complex 
associated  with  HuR–Grb7  using  coimmunoprecipitation  as-
says (Fig. 3 A). CRM1 was found in association with Grb7 
and  HuR,  and  the  association  was  almost  completely  abol-
ished upon treatment with the CRM1 inhibitor leptomycin B 
(LMB;  Fig.  3  B),  suggesting  a  specific  interaction  between 
CRM1 and HuR–Grb7 (Fig. 3 B). This finding was confirmed 
by  immunohistochemical  assays  in  the  DRG  neurons  and 
P19  cells  treated  with  LMB,  in  which  there  was  a  reduced 
cytoplasmic  localization  of  Grb7  (Fig.  3  C).  Fractionation 
experiments showed that LMB indeed reduced cytoplasmic ac-
cumulation of Grb7 in both control (Fig. 3 D) and EGF-treated   
(Fig. 3 E) P19 cells. The level of the Grb7–CRM1 immuno-
complex was drastically decreased by HuR knockdown (Fig. 3 F, 
top), which is consistent with GST pull-down data (Fig. 3 G). 
Importantly, 9 Grb7 did not coimmunoprecipitate with CRM1 
(Fig. 3 H), which confirmed the functional role of HuR in medi-
ating the formation of a Grb7–CRM1 complex.
Nuclear SHP-2 mediates the formation  
of an EGF-induced complex of Grb7, HuR, 
and CRM1
We have shown that the interaction between Grb7 and HuR is 
regulated  by  tyrosine  phosphorylation  of  Grb7  (Tsai  et  al., 
2008). Thus, we examined the tyrosine phosphorylation status 
of Grb7 in the nucleus and cytoplasm upon EGF treatment. 
LMB was used to block Grb7 export to obtain a quantitative 
measure of phosphorylated Grb7 in nucleus versus cytoplasm. 
Fig. 4 A showed reduced and increased tyrosine phosphorylation 
Results and discussion
EGF mediates Grb7-dependent activation of 
KOR levels and KOR mRNA nuclear export
We previously showed that axon guidance factor netrin-1 could 
regulate KOR mRNA translation through a FAK- and Grb7- 
dependent pathway (Tsai et al., 2006, 2007) and that KOR 
mRNA could be transported in neurons (Bi et al., 2006, 2007). 
The aim of this study was to identify regulatory signals for 
KOR posttranscriptional events, particularly in mobilizing 
mRNA, that could augment the functional KOR protein level 
in neurons. We found that EGF could play an important role. 
In a KOR ligand binding assay using 
3H-U69,593 of rat dorsal 
root ganglion (DRG) neurons (Fig. 1 A), we found that EGF 
increased 
3H-U69,593 binding to KOR, which was blocked by 
cold U69,593, dynorphin, or nor-binaltorphimine (nor-BNI). 
To determine the target of EGF action, we examined the level 
of EGF-stimulated KOR level in the presence of translational 
inhibitors (cycloheximide and puromycin) or a transcriptional 
inhibitor (actinomycin-D). Cycloheximide and puromycin re-
duced the amount of EGF-stimulated KOR protein, whereas 
actinomycin-D did not (Fig. 1 B). To determine the post-
transcriptional  target  of  EGF’s  action  in  elevating  the  KOR   
level, we examined Grb7, a previously identified KOR mRNA–
binding protein that recognizes its 5 untranslated region (Tsai 
et al., 2007). First, we asked whether Grb7 was involved in the 
effect of EGF on KOR expression using siRNA against Grb7 
(Fig. 1 C). The data showed that Grb7 knockdown reduced 
the effect of EGF on KOR expression, which was rescued   
by  expressing  siRNA-insensitive  Flag-Grb7  (see  Materials 
and methods).
We then examined the possibility that Grb7 might regulate 
KOR mRNA distribution using FISH. As shown in Fig. 1 D, 
KOR mRNA was concentrated in the nuclei of Grb7-specific 
siRNA–transfected DRG neurons and P19 cells but not in con-
trol cells, suggesting a possible role of Grb7 in KOR mRNA ex-
port. The effect of EGF on nuclear and cytoplasmic distribution 
of endogenous KOR mRNA in DRG neurons and P19 cells was 
confirmed to be Grb7 dependent (Fig. 1 E and Fig. S1). Next, 
we determined whether the subcellular distribution of Grb7 was 
also affected by EGF and found a reduction in nuclear Grb7 and 
an elevation in cytoplasmic Grb7 upon EGF treatment (Fig. 1 F). 
We then determined whether EGF enhanced the nuclear ex-
port of Grb7 by using a photoactivatable GFP (PAGFP)–fused 
Grb7. As shown in Fig. 1 G, export of selectively activated nu-
clear PAGFP-Grb7 to the cytoplasm was significantly faster in 
EGF-treated cells than in control cells. Together, these data sug-
gest that EGF triggers KOR mRNA nuclear export in a Grb7-
dependent manner.
Hu antigen R (HuR) is required for Grb7 
nuclear export
Grb7 does not mobilize RNA directly. However, Grb7 interacts 
with HuR (Tsai et al., 2008), a ubiquitously expressed RNA-
binding protein which can be associated with export complexes 
(Brennan  et  al.,  2000;  Rebane  et  al.,  2004)  to  regulate  the   
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is consistent with the time point at which nuclear Grb7 is   
dephosphorylated. Interestingly, the KOR protein level was 
readily elevated after only 30 min of EGF treatment, with or 
without LMB. These data suggest that the initial effect of EGF 
of nuclear and cytoplasmic Grb7, respectively, at 30 min and 
90 min of EGF treatment. Without LMB, a significant redistri-
bution of Grb7 (Fig. 4 A, bottom left) and KOR mRNA (Fig. 4 A, 
right) occurred after 90 and 120 min of EGF treatment, which 
Figure 1.  Grb7 mediates EGF-induced KOR levels and KOR mRNA nuclear export. (A) Quantitative KOR ligand binding assay of primary rat DRG neurons 
with 
3H-U69,593 in the presence or absence of EGF. Cold KOR agonists dynorphin and U69,593 and the antagonist nor-BNI were used for competition   
(*, P < 0.05). (B) Western blot analysis of primary rat DRG neurons (top) or P19 cells (bottom) in the presence or absence of EGF. Cycloheximide, puro-
mycin, or actinomycin-D was applied along with EGF. (C) Western blot analysis of P19 cells transfected with control siRNA, Grb7 siRNA, or Grb7 siRNA 
plus an siRNA-insensitive Flag-Grb7 in the presence or absence of EGF. (D) FISH of DRG neurons (top) and P19 cells (bottom) with a fluorescein-12–labeled 
probe specific to KOR mRNA. Cells were pretransfected with control (first and third rows) or Grb7 siRNA (second and fourth rows). Oligo (dT) was used as 
a control to hybridize total poly(A) RNA. Silencing of Grb7 was monitored by immunohistochemistry using an anti-Grb7 antibody. Colocalization of KOR 
mRNA and DAPI was quantified using the Pearson correlation coefficients and is shown on the right (*, P < 0.05). (E) RT-qPCR of KOR mRNA from nuclear 
or cytoplasmic fractions of rat DRG neurons or P19 cells. Control siRNA– or Grb7 siRNA–transfected cells in the presence or absence of EGF treatment 
are shown. CY, cytoplasmic fraction; NE, nuclear fraction. (F) Western blot analysis of nuclear and cytoplasmic fractions from P19 cells in the presence or 
absence of EGF. -Tubulin and lamin B served as the fractionation controls. (G) PAGFP-fused Grb7 was transfected into DRG neurons (top) and P19 cells 
(bottom). The images were obtained with a confocal microscope at the indicated time points. The quantified, relative cytoplasmic PAGFP-Grb7 signal from 
50 cells is shown on the right (*, P < 0.05). (D and G) White dotted lines outline the cytoplasm of individual cells. (A, D, E, and G) Error bars represent 
SDs. Bars, 25 µm.JCB • VOLUME 188 • NUMBER 3 • 2010   328
dephosphorylation of nuclear Grb7 was found to occur at resi-
dues phosphorylated by FAK because WT Flag-Grb7 but not 
the  dominant-negative  phosphorylation  mutant  (DM  Flag-
Grb7; Tsai et al., 2007) was effectively dephosphorylated by 
EGF treatment (Fig. 4 C). The specificity of SHP-2 to Grb7 was 
further validated by an in vitro phosphatase assay (Fig. 4 D) 
and immunoprecipitation experiments (Fig. S3). SHP-2 but not 
SHP-1 lowered the level of tyrosine phosphorylation on Grb7 
to 11%. Dephosphorylation of Grb7 was blocked by the SHP 
inhibitor NSC-87877 (Zhan et al., 2009), supporting the speci-
ficity of SHP-2 in dephosphorylating Grb7.
To validate SHP-2 as the activated phosphatase in re-
sponse to EGF stimulation, the effect of SHP-2 on Grb7 phos-
phorylation and complex formation of Grb7, HuR, and CRM1 was 
examined by siRNA knockdown of SHP-2 in P19 cells. Fig. 4 E  
demonstrated that EGF stimulated tyrosine dephosphorylation   
is to first enhance KOR translation, which is independent of 
the effect of EGF on KOR mRNA export that occurs later   
(Fig. 5, A and B).
To identify the phosphatase responsible for EGF-induced 
dephosphorylation of Grb7 in the nucleus, we examined a di-
rect interaction between the SHP-2 (Src homology region 2– 
containing phosphatase; Keegan and Cooper, 1996) and Grb7 
(Fig. S3) and performed a tyrosine phosphatase assay using 
immunoprecipitated SHP-2 extracted from untreated or EGF-
treated P19 cells. Fig. 4 B showed that SHP-2 activity was de-
tected in both the nucleus and the cytoplasm, but only nuclear 
SHP-2 was activated upon EGF treatment. Because activation 
of SHP-2 would depend on its interacting proteins (Poole and 
Jones, 2005), selective nuclear activation of SHP-2 might result 
from the formation of a specific complex containing SHP-2 
in the nucleus. This remains to be determined. EGF-stimulated 
Figure 2.  EGF induces HuR-dependent nuclear export of Grb7. (A) Immunohistochemistry of rat DRG neurons (top) and P19 cells (bottom) transfected with 
control or HuR siRNA. Colocalization of Grb7 and DAPI was quantified with the Pearson correlation coefficients and is shown on the right (*, P < 0.05). 
(B) Western blot analysis of nuclear and cytoplasmic fractions from P19 cells transfected as indicated in the presence or absence of EGF. (C) Mammalian 
two-hybrid assay in P19 cells transfected with Gal4-HuR and serial VP16-Grb7 deletion constructs. N-terminal deletions are named according to the number 
of deleted amino acid residues. (D) FISH detecting endogenous KOR mRNA in DRG neurons (top) and P19 cells (bottom) transfected with WT CFP-Grb7 
or 9 CFP-Grb7. Colocalization of KOR mRNA and DAPI was quantified with the Pearson correlation coefficients and is shown on the right (*, P < 0.05). 
(A and D) White dotted lines outline the cytoplasm of the individual cells. (A, C, and D) Error bars represent SDs. (E) Western blots of P19 cells transfected 
as indicated, in the presence or absence of EGF. Bars, 25 µm.329 Coordination of RNA export and translation • Tsai et al.
by the dominant-negative Flag-FAK-Y397F (Tsai et al., 2008). 
Importantly,  blocking  FAK  function  failed  to  inhibit  EGF-
stimulated Grb7 and KOR mRNA export (Fig. 5 A, right), sug-
gesting the specificity of FAK in phosphorylating cytoplasmic 
Grb7. Finally, EGF enhanced the protein level of KOR in cells 
expressing WT Grb7 but not in cells expressing a phosphoryla-
tion mutant of Grb7 (DM Flag-Grb7; Fig. 5 B), concluding that 
EGF-stimulated KOR translation is mediated by FAK phos-
phorylation of cytoplasmic Grb7.
Collectively, this study establishes a dual action of EGF 
through a novel mechanism that couples stimulated nuclear– 
cytoplasmic export of a KOR mRNA–protein complex and en-
hanced KOR translation in the cytoplasm (Fig. 5 C). A genetic 
approach would be needed to evaluate this pathway in the con-
text of whole animals in the future. Although a previous study 
showed posttranscriptional regulation in neurons by a cytoplas-
mic kinase (Hüttelmaier et al., 2005), this study provides the 
first example demonstrating mRNA mobilization and translation 
regulated by the dephosphorylation and phosphorylation of the 
same RNA-binding protein. Although HuR is known to use three 
different nuclear export machineries, Grb7 is only associated 
of Grb7 in the nucleus and enhanced complex formation of 
Grb7,  HuR,  and  CRM1.  Silencing  of  SHP-2  blocked  this 
complex formation (Fig. 4 E) and nuclear export of Grb7 and 
KOR mRNA (Fig. 4 F), which could be rescued by expressing 
siRNA  off-target  Flag–SHP-2  (see  Materials  and  methods). 
The interaction between HuR–CRM1 was not affected, con-
firming the specificity of SHP-2 in dephosphorylating Grb7 
and its subsequent complex formation with the HuR–CRM1 
export complex.
EGF activates cytoplasmic FAK-dependent 
KOR translation
Hypophosphorylated  Grb7  was  shown  to  bind  KOR  mRNA 
and silence its translation. FAK could phosphorylate Grb7 and 
thereby release KOR mRNA for translation (Tsai et al., 2007). 
As shown in Fig. 5 A, EGF induced an increase in the phos-
phorylation of cytoplasmic Grb7, which was blocked by FAK 
inhibitor PF 573228 (Slack-Davis et al., 2007) and FAK inhibi-
tor 14 (Golubovskaya et al., 2008) as well as by silencing FAK. 
The effect of silencing FAK was rescued by expressing siRNA-
insensitive WT Flag-FAK (see Materials and methods) but not 
Figure 3.  Nuclear export of Grb7 is mediated by CRM1 and HuR. (A) Western blot analysis of coimmunoprecipitation of Flag-tagged CRM1–, transportin 
1–, or transportin 2–transfected P19 cell lysates with anti-Grb7 or anti-HuR antibody. (B) Western blot analysis of coimmunoprecipitation of Grb7 and HuR 
from P19 cells with an anti-CRM1 antibody. (C) Immunohistochemistry of DRG neurons (top) and P19 cells (bottom) treated with or without LMB. White 
dotted lines outline the cytoplasm of individual cells. Colocalization of Grb7 and DAPI was quantified with Pearson correlation coefficients and is shown on 
the right (*, P < 0.05). Error bars represent SDs. (D) Western blot analysis of the nuclear and cytoplasmic fractions of P19 cells from cultures treated with 
or without LMB. (E) Western blot analysis of the nuclear and cytoplasmic fractions of P19 cells treated with EGF or EGF plus LMB. (D and E) -Tubulin and 
lamin B served as the fractionation controls. (F) Western blot analysis of CRM1 immunoprecipitation from P19 cells transfected as indicated. (G) Western 
blot analysis of control or HuR-silenced P19 cell lysates pulled down by GST or GST-CRM1. The GST protein input is shown on the right. Predicted GST 
proteins are marked with arrows. (H) Western blot analysis of anti-CRM1 precipitated from P19 cells transfected as indicated. (A, B, and F–H) A one-eighth 
input control is shown on the bottom. Ctrl, control; IB, immunoblot; IP, immunoprecipitation. Bars, 25 µm.JCB • VOLUME 188 • NUMBER 3 • 2010   330
Figure 4.  EGF activates nuclear SHP-2 to mediate complex formation of Grb7–HuR–CRM1. (A) Western blot analysis detecting nuclear or cytoplasmic 
Grb7 as well as tyrosine phosphorylated Grb7 in P19 cells treated with (top) or without (bottom) LMB and EGF as indicated. KOR was monitored, and 
-tubulin and lamin B provided the fractionation controls. The RT-qPCR result of KOR mRNA from nuclear (top right) or cytoplasmic (bottom right) fractions 
of P19 cells treated with EGF is shown on the right (*, P < 0.05). (B) Phosphatase assay from immunoprecipitated nuclear and cytoplasmic SHP-2 from 
control or EGF-treated P19 cells (*, P < 0.05). The precipitation efficiency and input control are shown on the bottom. (C) Western blot analysis detecting 
phospho-tyrosine and Flag from the nuclear fractions of P19 cells transfected as indicated with or without EGF treatment. -Tubulin and lamin B served as 
the fractionation controls. (D) Autoradiography of in vitro phosphatase assay on in vitro–prepared, anti-Flag antibody–precipitated WT or DM Flag-Grb7 
in the presence or absence of SHP-2 or -1 and the SHP inhibitor NSC-87877. A similar amount of input protein was confirmed by Western blotting with 
an anti-Flag antibody and is shown on the bottom. The predicted signals of Flag-Grb7 are indicated by an arrow, and the nonspecific signal is marked by 
pound sign. (E) Western blot analysis of Grb7 or CRM1 immunoprecipitation (IP) from nuclear extracts of P19 cells transfected as indicated. A one-eighth 
input is shown on the bottom. (F) Western blots analysis of nuclear and cytoplasmic fractions (top) and RT-qPCR assay of KOR (bottom left) or actin (bottom   
right) mRNA from P19 cells transfected as indicated with or without EGF treatment. (A, B, and F) Error bars represent SDs. CY, cytoplasmic fraction;   
IB, immunoblot; NE, nuclear fraction.331 Coordination of RNA export and translation • Tsai et al.
to dynamically modulate specific proteins (and mRNAs) that 
may be required to react to certain physiological needs instead 
of altering the global export system.
Materials and methods
Antibodies and reagents
The antibodies were purchased from Santa Cruz Biotechnology, Inc. (anti-
Grb7, anti-HuR, anti–SHP-2, anti–lamin B, anti–-tubulin, antiactin, anti-CRM1,   
anti-FAK, anti-EGF, anti–EGF receptor, and anti–phospho-FAK), Millipore 
(anti-GST and anti–phospho-tyrosine), Abcam (anti-KOR), and Sigma-Aldrich 
(anti-Tau and anti-Flag). EGF, rapamycin, LMB, cycloheximide, puromycin, 
actinomycin-D, DAPI, U69,593, nor-BNI, and dynorphin were purchased 
from Sigma-Aldrich. PF 573228 and FAK inhibitor 14 were obtained from 
Tocris Bioscience. NSC-87877 was obtained from EMD. 
3H-U69,593 was 
obtained from PerkinElmer.
with  CRM1  through  interaction  with  HuR. These  data  sug-
gest that other factors or molecules might be involved in either 
promoting  KOR  mRNA–Grb7–HuR  interaction  with  CRM1 
or prohibiting the interaction of Grb7 with the two transportin 
complexes. Because the nuclear and cytoplasmic distribution of 
SHP-2 was not affected by EGF treatment, the pathways trans-
mitting the membrane EGF signal to the nucleus remain to be 
examined. Also, nuclear export of HuR is not affected by EGF, 
suggesting an interesting possibility that the nuclear export of 
a specific mRNA engages only certain specific RNA-associated 
proteins (in this case through Grb7). Upon stimulation, these 
specific  RNA-associated  protein  complexes  recruit  the  con-
stitutively active housekeeping nuclear–cytoplasmic shuttling   
machinery. Presumably, it would be more economical for cells 
Figure 5.  EGF activates cytoplasmic FAK to enhance KOR translation in the cytoplasm. (A) Western blot analysis detecting KOR, Grb7, and anti–phospho-
tyrosine–immunoprecipitated Grb7 from the cytoplasmic (top) or nuclear (bottom) fractions of P19 cells. FAK, phospho-FAK (pFAK), Flag, Grb7, and actin 
serve as the controls for transfection and input. RT-qPCR assays of KOR and actin mRNA are shown on the right. Error bars represent SDs. CY, cytoplasmic 
fraction; NE, nuclear fraction. (B) Western blot analysis of P19 cells transfected as indicated and in the presence or absence of EGF. (C) Model of EGF’s 
dual action to elevate the level of KOR. Without EGF, nuclear SHP-2 and cytoplasmic FAK are inactive (i–SHP-2 and i-FAK). Upon EGF stimulation, unknown 
pathways activate nuclear SHP-2 (a–SHP-2), which dephosphorylates nuclear Grb7. Dephosphorylated nuclear Grb7 recruits KOR mRNA and HuR to form 
a nuclear export complex, thereby shuttling KOR mRNA to the cytoplasm. EGF also activates cytoplasmic FAK (a-FAK), which phosphorylates the preexisting 
cytoplasmic and nuclear-exported Grb7, releasing KOR mRNA for translation.JCB • VOLUME 188 • NUMBER 3 • 2010   332
for 30 min, primary antibodies were diluted 1:200 with blocking buffer 
and applied to the fixed cells overnight at 4°C. After washing three times 
with PBS, Cy3-, Cy5-, or FITC-conjugated secondary antibodies were di-
luted 1:500 and applied to the cells for another 2 h at room temperature in 
the dark. After additionally washing the cells three times and a 5-min DAPI 
stain,  the  cells  were  observed  on  an  inverted  fluorescence  microscope 
(IX70; Olympus). Images were acquired by Image ProPlus software (Media 
Cybernetics) and merged by Photoshop (Adobe). To track PAGFP-fused 
Grb7, transfected DRG neurons or P19 cells were treated with EGF and 
supplied with a CO2-independent medium (Invitrogen) before acquiring the 
images. After EGF treatment for 90 min, the cells were placed on a heating 
plate set at 37°C. The nucleus of the selected cell (nucleus was determined 
under brightfields) was excited at 405 nm and observed with a confocal 
microscope (FluoView FV1000; Olympus) equipped with a 60× NA 1.42 
Plan-Apochromat oil immersion lens at 488 nm.
Quantification of digital images
The GFP signal from PAGFP-Grb7–transfected cells was directly measured 
by FV1000 viewer software (Olympus) simultaneously as the images were 
being taken. Three areas from an individual cell, and a total 20 cells, were 
analyzed. To quantify colocalization of the overlaid images, three indepen-
dent sets of experiments with a total of 50 ± 5 cells were analyzed. Z stacks 
(optical sections) of the images were collected by a FluoView FV1000 
confocal microscope at an optical thickness of 0.2 µm. Colocalization of 
multiple sets of optical images was quantified by WCIF ImageJ software 
(National Institutes of Health), where Pearson’s r values (Pearson correla-
tion coefficients) were obtained (Leil et al., 2004; Segret et al., 2007).
Tyrosine phosphatase assay and in vitro kinase/phosphatase assay
The phosphatase activity assay was performed according to the manufac-
ture’s protocol (Tyrosine Phosphatase Assay System; Promega). In brief, immuno-
precipitated SHP-2 from P19 cells was incubated in the supplied reaction 
buffer with 1 mM tyrosine phosphopeptides for 20 min. The reaction was 
stopped by adding a molybdate dye mixture, and the free phosphate was 
detected at 630 nm. The kinase reaction was performed by using immuno-
precipitated FAK, and the complex was washed (50 mM Tris–HCl, pH 7.5,   
3 mM MnCl2, 3 mM MgCl2, and 100 mM NaCl). Flag-Grb7 was incu-
bated with precipitated FAK in the presence of -[
32P]ATP for 30 min at 
37°C and analyzed by SDS-PAGE, followed by PhosphoImager (Molecular 
Dynamics) detection. The phosphatase assays were performed by adding 
immunoprecipitated SHP-2 or -1 to the kinase reaction for another 30 min 
with or without the SHP inhibitor NSC-87877. The final reaction mixture 
was then subjected to SDS-PAGE and analyzed by PhosphorImager.
Mammalian two-hybrid assay and quantitative RT-PCR (RT-qPCR)
The mammalian two-hybrid assay was performed by transfecting cells with 
0.1 µg pBD-Gal4-HuR together with a series of 0.1 µg of N terminus– 
deleted  pAD-Gal4-Grb7  constructs.  All  cotransfections  also  included   
0.25 µg of the Gal4-tk-luciferase reporter and 0.05 µg of a CMV-lacZ 
internal control. 30 h after transfection, cells were lysed, and the luciferase 
activity was determined. For RT-qPCR, P19 cells or DRG neurons were frac-
tionated into cytoplasmic and nuclear fractions with the NE-PER Nuclear and 
Cytoplasmic Extraction Reagents kit. Total RNA was then extracted from the 
fractions with TRIZOL reagent (Invitrogen). The purified RNA was subjected 
to reverse transcription reactions with a cDNA synthesis kit (QIAGEN).   
The cDNA was used for real-time PCR using a SYBR green quantitative 
PCR kit (Agilent Technologies). The specific primer pairs for real-time PCR 
were  as  follows:  KOR,  5-CATCATCAGGAAACTGCA-3  and  5-TGGT-
CATGTTTGTCATC-3; and -actin, 5-TGGCCTTAGGGTGCAGGG-3 and 
5-GTGGGCCGCTCTAGGCACCA-3.
Statistical analysis
The data in this study are presented as the mean ± SD and were analyzed 
with the Student’s t test, where P < 0.05 was considered significant.
Online supplemental material
Fig. S1 shows the corresponding control of actin mRNA and Grb7 silencing 
efficiency of Fig. 1 E. Fig. S2 reveals that 9 Grb7 lost its affinity for HuR but 
retained its RNA-binding ability. Fig. S3 confirms that Grb7 directly interacts 
with SHP-2 and that SHP-2 but not SHP-1 mediates nuclear dephosphoryla-
tion of Grb7 after EGF treatment. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200910083/DC1.
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Plasmid constructs, siRNAs, restoration experiments, and transfection
The generation of GST-Grb7, GST-HuR, WT Flag-Grb7, DM Flag-Grb7, 
WT Flag-FAK, Flag-FAK-Y397F, and Flag-HuR was described previously   
(Tsai et al., 2007, 2008). Flag–SHP-2 was constructed by subcloning   
SHP-2 cDNA (provided by C.-K. Qu, Case Western Reserve University, Cleve-
land, OH) into Flag-tagged pCMX. Gal4-HuR was constructed by inserting 
full-length HuR cDNA into EcoRI–XbaI-digested pM (Takara Bio Inc.). Full-
length and deleted Grb7 constructs were cloned into EcoRI–XbaI-digested 
pVP16 (Takara Bio Inc.). The 9-aa deleted (9) Flag-Grb7 and GST-Grb7 
were cloned into BamHI–NheI-digested pCMX and BamHI–NotI-digested   
pGEX-2T (GE Healthcare). CFP-tagged WT Grb7, 9 Grb7, and DM Grb7 
were constructed by amplifying the Flag-tagged constructs and cloning 
them into BglII–BamHI-digested pECFP-C1 (Takara Bio Inc.). PAGFP-fused 
WT Grb7 was constructed by amplifying Flag-tagged constructs and clon-
ing them into BglII–BamHI-digested pPAGFP-C1 (Addgene). Flag-tagged 
CRM1 and transportin 1 and 2 were cloned into BamHI–NheI-digested 
pCMX. GST-CRM1 was constructed by inserting full-length CRM1 cDNA 
into BamHI–HindIII-digested pGEX-2T (GE Healthcare). siRNAs were all 
purchased from QIAGEN. The targeting sequences are as follows: Grb7, 
5-AGGATTCGAAATCAAATCCAA-3  and  5-TAGCCGCTTCATCTTCCG-
TAA-3; HuR, 5-CAGAAACATTTGAGCATTGTA-3 and 5-AAAGTATATAT-
TAAAGTGAAA-3;  SHP-2,  5-CAGAGTATTAAAGAAATATAA-3  and 
5-AAGAGTTACATTGCCACTCAA-3; and SHP-1, 5-CCCTTCTATTCTTG-
TAAATAA-3  and  5-TGGGAGGAGTTTGAGAGTCTA-3  or  were  previ-
ously described (Tsai et al., 2007). The siRNA-insensitive Flag-Grb7 and 
Flag-FAK were made by mutating the cDNA sequences to reduce their 
complementarity to siRNAs without changing their protein sequences (Tsai 
et al., 2007). In the cases of siRNA off-target Flag-HuR and Flag–SHP-2,   
siRNAs were made to target the untranslated regions of the endogenous 
genes without affecting full-length Flag construct expression. Plasmid trans-
fections were performed using Lipofectamine 2000 (Invitrogen), and siRNA 
transfections were performed by Hyperfect reagent (QIAGEN).
Cell culture and nuclear–cytoplasmic fractionation
P19 cells and DRG neurons were cultured as previously described (Tsai 
et al., 2006) with slight modification. In DRG culture, to exclude extrinsic 
effects on KOR expression, NGF and N2 supplements were excluded from 
the medium during DRG culture. All experiments were performed within   
5 d after initial plating to avoid neuronal death because of the lack of NGF. 
On the second day after plating, EGF was added at a final concentration 
of 100 µg/ml. Nuclear–cytoplasmic fractionation was conducted using the 
NE-PER Nuclear and Cytoplasmic Extraction Reagents kit (Thermo Fisher 
Scientific) according to the manufacturer’s protocol.
Immunoprecipitation, GST pull-down, Western blotting, and ligand 
binding assay
For immunoprecipitation, cells were sonicated and incubated with anti-
bodies for 1 h at 4°C and then with protein G beads for another 1 h. After 
washing three times, the samples were subjected to SDS-PAGE analysis 
followed by Western blotting. In the assays, IgG was used as a control 
antibody. For GST pull-down, GST-Grb7 proteins were bound to gluta-
thione beads and incubated with total protein extract of P19 for 1 h. After 
washing, the samples were subjected to SDS-PAGE and Western blotting 
analysis. For Western blotting after SDS-PAGE, the gel was transferred 
onto a polyvinylidene fluoride membrane. After blocking with a 5% milk 
solution, the membrane was incubated with the primary antibody for 2 h at 
room temperature, followed by a 30-min washing with PBS. The membrane 
was then incubated with an HRP-conjugated secondary antibody for 1 h, 
followed by another 30-min washing. The membrane was then developed 
with a SuperSignal West Pico kit (Thermo Fisher Scientific). For ligand 
binding, primary DRG neurons were first treated with or without EGF for   
6 h, followed by the addition of 1 µM 
3H-U69,593 along with or with-
out nor-BNI, dynorphin, or unlabeled U69,593 for another 20 min. After 
washing, the cell pellet was collected, and 
3H counts were determined by 
a liquid scintillation counter (LS 6500; Beckman Coulter).
FISH and in vitro transcription
RNA  probes  for  FISH  were  verified  and  synthesized  as  previously  de-
scribed (Bi et al., 2006) with fluorescein-12–UTP (Roche). FISH in DRG 
neurons or P19 cells with a synthesized probe or oligo (dT) was described 
previously (Tsai et al., 2009).
Immunohistochemistry and image acquisition
DRG neurons or P19 cells were fixed with ice-cold buffer (3% paraformal-
dehyde and 5% sucrose in PBS) for 15 min followed by permeabilization 
with 0.5% Triton X-100 in PBS for 5 min. After blocking (1% BSA in PBS) 333 Coordination of RNA export and translation • Tsai et al.
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